200780 Stock Splits - BCWorldPharm Co Ltd

Watchlist Manager

Watchlist

Price: 4 780 KRW -2.15% Market Closed

Market Cap: ₩51B

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US
	Walt Disney Co NYSE:DIS	US
	PayPal Holdings Inc NASDAQ:PYPL	US

The company executed a 11-for-10 stock split, meaning that for every 10 shares held, investors received 11 new shares.

Before the split, BCWorldPharm Co Ltd traded at 5620.0005 per share. Afterward, the share price was about 5440.

The adjusted shares began trading on Dec 29, 2025. This was BCWorldPharm Co Ltd's 5th stock split, following the previous one in Dec 27, 2024.

Dec 29, 2025

11-for-10

Dec 27, 2024

11-for-10

Dec 27, 2019

11-for-10

Dec 27, 2017

11-for-10

Dec 28, 2016

11-for-10

Pre-Split Price

5 009.0914 5 620.0005

Post-Split Price

5 440

Adjust Price

Dec 29, 2025

11-for-10

Dec 27, 2024

11-for-10

Dec 27, 2019

11-for-10

Dec 27, 2017

11-for-10

Dec 28, 2016

11-for-10

BCWorldPharm Co Ltd
Stock Splits History

Logarithmic

Dec 29, 2025

Split 11-for-10

x1.1

Pre-Split Price

5 009.0914 5 620.0005

Post-Split Price

5 440

Adjust Price

Dec 27, 2024

Split 11-for-10

x1.1

Pre-Split Price

3 905.5035 4 930.0009

Post-Split Price

4 171.2718

Adjust Price

Dec 27, 2019

Split 11-for-10

x1.1

Pre-Split Price

10 530.959 15 300.0044

Post-Split Price

10 981.5914

Adjust Price

Dec 27, 2017

Split 11-for-10

x1.1

Pre-Split Price

14 692.0491 23 700.0091

Post-Split Price

15 208.9786

Adjust Price

Dec 28, 2016

Split 11-for-10

x1.1

Pre-Split Price

15 295.0614 27 250.0131

Post-Split Price

15 900.8886

Adjust Price

Global
Stock Splits Monitor

Forward Splits

Reverse Splits

Adjust Price

Date	Company		Split	Pre-Split Price	Post-Split Price
Apr 20, 2026		Fast Fitness Japan Inc TSE:7092 7092 Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-4554450 /4554450	2303 999999.9999 JPY	N/A
Apr 17, 2026	S	Shenzhen Best of Best Holdings Co Ltd SZSE:001298 001298 Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-1 x1	30.47 20.9438 CNY	21.98 21.98 CNY
Apr 17, 2026	P	Pt Harta Djaya Karya Tbk IDX:MEJA MEJA Valuation & Fundamental Analysis Stock Splits Performance Benchmark	7-for-6 x1.1666666666667	118.0001 101.1429 IDR	111 111 IDR
Apr 17, 2026		Yesco Holdings Co Ltd KRX:015360 015360 Valuation & Fundamental Analysis Stock Splits Performance Benchmark	5-for-1 x5	80000 16000 KRW	16110 16110 KRW
Apr 17, 2026	P	Powell Max Ltd NASDAQ:PMAX PMAX Valuation & Fundamental Analysis Stock Splits Performance Benchmark	1-for-10 /10	0.221 2.21 USD	2.53 2.53 USD

BCWorldPharm Co Ltd
Glance View

Market Cap

51B KRW

Industry

Pharmaceuticals

BCWORLD PHARM.Co., Ltd. engages in the manufacture and development of pharmaceutical products. The company is headquartered in Yeoju, Gyeonggi-Do. The company went IPO on 2014-12-15. The firm's products include anesthetic pain medication such as cancer pain treatment, muscle relaxants, anesthesia and pain relief drugs; circulation contracts such as hypertension and hyperlipidemia; antibiotics such as tuberculosis treatment; other prescription drugs such as peptic ulcer and osteoporosis. In addition, the Company develops improved drugs and new products.

View BCWorldPharm Co Ltd Analysis

Intrinsic Value

Undervaluation 12%

Intrinsic Value

Price ₩4 780

What is Intrinsic Value?

Join more than 331,800+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.